Aldosterone-producing adrenal adenoma and idiopathic intracranial hypertension-a pathogenetic link for aldosterone?

QJM: An International Journal of Medicine

Volumn 103, Issue 9, 2010, Pages 699-702

  Chitalia, Nihil ^a   Weeg, Natalie ^a   Antonios, Tarek F T ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALDOSTERONE; AMILORIDE; AMLODIPINE; PERINDOPRIL;

ADRENAL CORTEX ADENOMA; ADRENAL GLAND; ADRENALECTOMY; ADULT; ANAMNESIS; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRAIN SCINTISCANNING; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CATECHOLAMINE URINE LEVEL; CEREBROSPINAL FLUID PRESSURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPOKALEMIA; IDIOPATHIC DISEASE; INTRACRANIAL HYPERTENSION; LUMBAR PUNCTURE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; PAPILLEDEMA; PATHOGENESIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; VISUAL ACUITY; VISUAL DISORDER;

EID: 77955905569     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcq016     Document Type: Article

References (14)

1. Weber KT, Singh KD, Hey JC. Idiopathic intracranial hypertension with primary aldosteronism. Report of two cases. Am J Med Sci 2002; 324:45-50.
2. Dougherty GN, Zafarullah H, Nelson MD, Malhotra A, Weber KT. Primary Aldosteronism in a Patient with Idiopathic Intracranial Hypertension. J Investig Med 2005; 53:S257.
3. Young WF. Minireview: primary aldosteronism-changing concepts in diagnosis and treatment. Endocrinology 2003; 114:2208-13.
4. Shah VA, Kardon RH, Lee AG, Corbett JJ, Wall M. Long term follow up of idiopathic intracranial hypertension: the Iowa experience. Neurology 2008; 70:634-40.
5. Weber KT. Aldosterone revisited: perspectives on less wellrecognised actions of aldosterone. J Lab and Clin Med 2003; 142:71-82.
6. Go KS. The normal and pathological physiology of brain water. Adv Tech Stand Neurosurg 1997; 23:47-142.
7. Gomez-Sanchez EP. Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology 1986; 118:819-23.
8. Wang H, Huang BS, Leenen FH. Brain sodium channels and ouabain-like compounds mediate central aldosteroneinduced hypertension. Am J Physiol Heart Circ Physiol 2003; 285:H2516-23.
9. Ames A, Higashi K, Nesbett FB. Effects of PCO2, acetazolamide and ouabain on volume and composition of choroidplexus fluid. J Physiol 1965; 181:516-24.
10. Klarr SA, Keep RF, Betz AL. Chronic central potassium infusion prevents deoxycorticosterone-salt hypertension in rats. Am J Physiol 1995; 268:H646-52.
11. Yu Y, Wei S-G, Zhang Z-H, Gomez-Sanchez G, Weiss RM, Felder RB. Does aldosterone upregulate the brain reninangiotensin system in rats with heart failure? Hypertension 2008; 51:727-33.
12. Mendonca E, Albuquerque L, Jacome L, Luis LM, Rosa FC. Pseudotumour cerebri in a patient with Bartter's syndrome and obesity. Nephron 1996; 71:98-9.
13. Gregoric A, Bracic K, Novljan G, Marcum-Varda N. Pseudotumor cerebri in a child with familial hypomagnesemia-hypercalciuria. Pediatr Nephrol 2000; 14:269-70.
14. Godefroid N, Riveira-Munoz E, Saint-Martin C, Nassogne MC, Dahan K, Devuyst O. A novel splicing mutation in SLC12A3 associated with Gitelman syndrome and idiopathic intracranial hypertension. Am J Kidney Dis 2006; 48:e73-9.